March 29, 2019 — Taking a high dose of icosapent ethyl significantly reduces the occurrence of first, subsequent and ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
March 29, 2019
![New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/valsartan (Entresto) continued to deliver reductions in the heart failure biomarker N-terminal pro–B-type natriuretic peptide (NT-proBNP), an established biomarker for heart failure severity and prognosis.[1] The data was presented as a late-breaker at the American College of Cardiology (ACC) 2019 Annual Scientific Session in March.](/sites/default/files/styles/content_feed_medium/public/Entresto_bottles.jpg?itok=sp56E5GI)
March 27, 2019 —New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril ...
March 27, 2019
March 25, 2019 — Patients who stopped taking aspirin one month after receiving a stent in the heart’s arteries but ...
March 25, 2019
March 25, 2019 — Phase 3 results from Study 2, also known as CLEAR WISDOM, of bempedoic acid were recently presented at ...
March 25, 2019
March 19, 2019 — The Bristol-Myers Squibb-Pfizer Alliance announced results from the Phase 4 AUGUSTUS trial evaluating ...
March 19, 2019
The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.19 ...
March 19, 2019
March 18, 2019 — The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a ...
March 18, 2019
February 19, 2019 — A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and ...
February 19, 2019
Feature | Dave Fornell, Editor
February 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) m ...
February 01, 2019
January 31, 2019 — Researchers have mapped the active-state structure of the angiotensin II type 1 receptor, the target ...
January 31, 2019
January 30, 2019 — Updated atrial fibrillation (AFib) treatment guidelines released this week now recommend new oral ...
January 30, 2019
Here are a few of the takeaways from the clinical studies presented and new technology shown on the exhibit floor at the ...
January 14, 2019
January 10, 2019 — Aurobindo Pharma USA Inc. is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets ...
January 10, 2019
Feature | Dave Fornell, Editor
January 4, 2018 — Here is the top cardiology content on the Diagnostic and Interventional Cardiology (DAIC) website from ...
January 04, 2019
January 3, 2019 — Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage ...
January 03, 2019© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now